Abstract | BACKGROUND: METHODS: A weight-drop device was used to deliver a standard traumatic impact to rats. Western blot, RT-PCR and ELISA were used to analyze the expression of Nogo-A and IL-1β. Nogo-A antisense, and an irrelevant control oligonucleotide was intracerebroventricularly infused. We also performed H & E staining and luxol fast blue staining to evaluate the neuronal damage and demyelination resulting from TBI and various treatments. RESULTS: Based on RT-PCR and western blot analyses, the expression of Nogo-A was found to be significantly upregulated in the hippocampus beginning eight hours after TBI. In addition, TBI caused an apparent elevation in IL-1β levels and severe neuronal damage and demyelination in the tested animals. All of the TBI-associated molecular and cellular consequences could be effectively reversed by treating the animals with the anti-inflammatory drug indomethacin. More importantly, the TBI-associated stimulation in the levels of both Nogo-A and IL-1β could be effectively inhibited by a specific Nogo-A antisense oligonucleotide. CONCLUSIONS: Our findings suggest that the suppression of Nogo-A expression appears to be an early response conferred by indomethacin, which then leads to decreases in the levels of IL-1β and TBI-induced neuron damage.
|
Authors | Po-Kuan Chao, Kwok-Tung Lu, Ji-Yi Jhu, Yu-Yuan Peter Wo, Tai-Chun Huang, Long-Sun Ro, Yi-Ling Yang |
Journal | Journal of neuroinflammation
(J Neuroinflammation)
Vol. 9
Pg. 121
(Jun 07 2012)
ISSN: 1742-2094 [Electronic] England |
PMID | 22676811
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Interleukin-1beta
- Myelin Proteins
- Neuroprotective Agents
- Nogo Proteins
- Rtn4 protein, rat
- Indomethacin
|
Topics |
- Animals
- Brain Injuries
(drug therapy, metabolism, pathology)
- Hippocampus
(drug effects, metabolism)
- Indomethacin
(pharmacology, therapeutic use)
- Interleukin-1beta
(antagonists & inhibitors, metabolism)
- Male
- Myelin Proteins
(antagonists & inhibitors, biosynthesis, genetics)
- Neurons
(drug effects, metabolism, pathology)
- Neuroprotective Agents
(pharmacology, therapeutic use)
- Nogo Proteins
- Rats
- Rats, Wistar
|